EUVIMEDEUVIMED entdecken
Crossref

PRECLINICAL EVALUATION OF HER2-DIRECTED CAR T-CELL THERAPY IN HER2-POSITIVE CHOLANGIOCARCINOMA

Maen Abdelrahim, Zhiwu Jiang, Abdullah Esmail, Yiran Zhu, Ziyi Peng, Hui Xing, Jing Fang, Pan Su, Lu Yong

HPB · 2026 · 28 · S24

DOI: 10.1016/j.hpb.2026.04.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HPB, 2026. Verfasst von Maen Abdelrahim und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abdelrahim, M., Jiang, Z., Esmail, A., Zhu, Y., Peng, Z., Xing, H., Fang, J., Su, P., & Yong, L. (2026). PRECLINICAL EVALUATION OF HER2-DIRECTED CAR T-CELL THERAPY IN HER2-POSITIVE CHOLANGIOCARCINOMA. HPB, 28, S24. https://doi.org/10.1016/j.hpb.2026.04.040

Vancouver

Abdelrahim M, Jiang Z, Esmail A, Zhu Y, Peng Z, Xing H, et al. PRECLINICAL EVALUATION OF HER2-DIRECTED CAR T-CELL THERAPY IN HER2-POSITIVE CHOLANGIOCARCINOMA. HPB. 2026;28:S24. doi:10.1016/j.hpb.2026.04.040

BibTeX
@article{Abdelrahim2026,
  author = {Abdelrahim, Maen and Jiang, Zhiwu and Esmail, Abdullah and Zhu, Yiran and Peng, Ziyi and Xing, Hui and Fang, Jing and Su, Pan and Yong, Lu},
  title = {PRECLINICAL EVALUATION OF HER2-DIRECTED CAR T-CELL THERAPY IN HER2-POSITIVE CHOLANGIOCARCINOMA},
  journal = {HPB},
  year = {2026},
  volume = {28},
  pages = {S24},
  doi = {10.1016/j.hpb.2026.04.040}
}
Kostenlos starten →